COVID-19 has brought to light the issues of European manufacturing capabilities, leading industry to question whether it is now time to reinvest in domestic medicines supply.
Tony Cordrey
Advertisement
Tony Cordrey is vice‑president of European Strategic Operations, Accord Healthcare.
Articles by Tony Cordrey
Advertisement
Latest Updated Articles
Reinvesting in European ManufacturingPublished: August 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Leveraging AI/ML to Reduce Risk in Drug Development: Part One
2
Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care
3
Implications on SMA Care of High-Dose Nusinersen
4
New Targets for Clinical Trials in the European Union
5
